Around 47,700 men are diagnosed with prostate cancer in the UK each year, making it the most common cancer in men in the UK. It develops in the prostate, a walnut-sized gland found at the base of the bladder.
We take a look at results from the STAMPEDE clinical trial, which is researching how to improve treatment for men with prostate cancer.
Meet our new leaders, who are spearheading research to tackle some of the biggest questions we need to answer to help more people survive cancer.
A clinical trial of a type of laser treatment for prostate cancer hit the headlines. What do the results mean for patients? We spoke to an expert to find out.
Here are our highlights from day 3 of the NCRI Cancer Conference, including personalised treatment for prostate cancer, and new surgery tech.
The results of a clinical trial testing radiotherapy doses for treating prostate cancer should be good news for men.
We look at the latest round of innovative and exciting new projects we’re funding in population research.
Find out the details of the nine ideas that could answer one of our Grand Challenges in cancer prevention, diagnosis and treatment.
We look at the fourth of our Grand Challenges and ask the experts how we can find ways to tell the difference between lethal and non-lethal tumours.